Smith Salley & Associates cut its position in Henry Schein Inc. (NASDAQ:HSIC) by 10.8% during the second quarter, Holdings Channel reports. The institutional investor owned 1,441 shares of the company’s stock after selling 175 shares during the period. Smith Salley & Associates’ holdings in Henry Schein were worth $255,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of the company. Zurich Insurance Group Ltd FI purchased a new stake in Henry Schein during the first quarter worth approximately $3,204,000. National Pension Service increased its stake in Henry Schein by 4.4% in the first quarter. National Pension Service now owns 56,059 shares of the company’s stock worth $9,677,000 after buying an additional 2,383 shares in the last quarter. AMP Capital Investors Ltd increased its stake in Henry Schein by 1.7% in the first quarter. AMP Capital Investors Ltd now owns 23,958 shares of the company’s stock worth $4,141,000 after buying an additional 400 shares in the last quarter. Citizens Financial Group Inc RI increased its stake in Henry Schein by 1.0% in the first quarter. Citizens Financial Group Inc RI now owns 46,377 shares of the company’s stock worth $8,006,000 after buying an additional 452 shares in the last quarter. Finally, Prudential PLC increased its stake in Henry Schein by 57.5% in the first quarter. Prudential PLC now owns 6,300 shares of the company’s stock worth $1,088,000 after buying an additional 2,300 shares in the last quarter. 92.03% of the stock is currently owned by institutional investors.
Henry Schein Inc. (NASDAQ:HSIC) traded up 0.09% during mid-day trading on Monday, reaching $153.50. The company had a trading volume of 265,451 shares. Henry Schein Inc. has a 12 month low of $142.64 and a 12 month high of $183.00. The firm’s 50-day moving average price is $162.17 and its 200-day moving average price is $170.06. The stock has a market cap of $12.56 billion, a PE ratio of 26.00 and a beta of 1.05.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Thursday, August 4th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.63 by $0.01. Henry Schein had a return on equity of 17.84% and a net margin of 4.42%. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.85 billion. During the same quarter in the prior year, the business earned $1.46 EPS. The business’s revenue for the quarter was up 9.3% compared to the same quarter last year. Equities research analysts forecast that Henry Schein Inc. will post $6.57 EPS for the current fiscal year.
A number of equities analysts recently issued reports on HSIC shares. Goldman Sachs Group Inc. upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 target price on the stock in a report on Tuesday, October 11th. Bank of America Corp. started coverage on Henry Schein in a report on Monday, September 12th. They issued a “buy” rating and a $185.00 target price on the stock. Zacks Investment Research upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Monday, September 12th. Finally, Robert W. Baird cut Henry Schein from an “outperform” rating to a “neutral” rating and decreased their target price for the stock from $176.00 to $164.00 in a report on Friday. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Henry Schein currently has a consensus rating of “Hold” and an average target price of $159.50.
In other news, Director Paul Brons sold 3,381 shares of the stock in a transaction on Monday, August 29th. The stock was sold at an average price of $164.03, for a total value of $554,585.43. Following the transaction, the director now owns 13,715 shares of the company’s stock, valued at approximately $2,249,671.45. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.27% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.